Immediate Suspension Order (ISO)

An Immediate Suspension Order (ISO) is a DEA emergency action under 21 USC 824(d) that suspends a DEA registration immediately upon service, stopping the registrant from dispensing, prescribing, or distributing controlled substances within 24 hours. DEA must determine that the continued registration presents an imminent danger to the public health and safety. The ISO runs alongside (and may precede) an Order to Show Cause proceeding on the merits. Federal district court challenge is available under 21 USC 824(d)(2).

How an ISO works

DEA issues the ISO from DEA Headquarters following a Diversion Investigator case package and senior-management approval. The order is served on the registrant typically by a DEA Diversion Investigator in person, with simultaneous notice to any affected entities (pharmacy chain owners, group practices, distributors). The suspension takes effect on service. The registrant cannot legally handle controlled substances from that moment forward; failure to comply is a federal offense.

The procedural defenses run on three tracks. First, the administrative track: the underlying Order to Show Cause proceeds before a DEA Administrative Law Judge with the registrant requesting a hearing and presenting the case on the merits. Second, the federal district court track: under 21 USC 824(d)(2), the registrant can file in federal district court for a hearing on whether the imminent-danger determination was justified. Third, the negotiation track: where the underlying conduct can be remediated through corrective action, the parties can negotiate a return to compliance under a Memorandum of Agreement or a Corrective Action Agreement before the administrative proceeding concludes.

When an ISO applies

An ISO is reserved for matters where DEA concludes that continued registration presents an imminent danger to public health and safety. Common triggers include: ongoing diversion patterns detected through inventory reconciliation or pattern analysis; corresponding-responsibility failures of severe magnitude; criminal indictment of the registrant or its principals; ongoing dispensing of controlled substances to known diverters; and pattern findings that justify emergency intervention before the administrative proceeding can complete.

The registrant's exposure under an ISO

Immediate cessation of controlled substance operations is the most acute exposure. For a pharmacy, that typically means closing the controlled substance side of operations until the matter resolves. For a prescriber, it ends the ability to prescribe controlled substances. Inventory must be safeguarded; sale or transfer requires DEA approval. Reputational exposure runs through DEA's published ISO actions. Parallel criminal exposure under 21 USC 841 runs alongside the administrative ISO proceeding where the underlying conduct supports prosecution. The defense framework focuses on the federal district court challenge under 824(d)(2), expert testimony on the imminent-danger determination, the Administrative Law Judge hearing record, and parallel criminal-track coordination.

Related terms

• DEA Order to Show Cause The administrative proceeding on the merits that runs alongside or after the ISO.
• Suspicious Order Monitoring The DEA compliance framework whose failures often support ISO actions against distributors.
• Inventory reconciliation The audit technique that often produces the pattern findings supporting an ISO.
• Target letter The DOJ notification that may accompany an ISO where criminal investigation runs in parallel.

See also

• Practice area
  DEA Defense

  The full DEA defense framework, including ISO challenge under 824(d)(2) and the parallel OSC proceeding.

• Practice area
  DEA Inspections Defense

  Defense framework for DEA inspections that often produce the findings supporting an ISO.